Similarly, a study of freshly isolated patient-derived GBM cells showed that within a sorted population of c-MET-positive cells, those with high c-MET expression were more clonogenic, and more tumorigenic in an orthotopic in vivo model, than those with lower c-MET expression (112). This evidence concerns the gene MET and glioblastoma.